文献速递血栓与止血MDS 与骨髓增殖性肿瘤

血小板与中性粒细胞协同促进JAK2V617F骨髓增殖性肿瘤中中性粒细胞胞外诱捕网形成增加

Platelets and neutrophils cooperate to induce increased neutrophil extracellular trap formation in JAK2V617F myeloproliferative neoplasms.
PubMed 文献 · J Thromb Haemost · 2023-09-09

本研究在小鼠模型和患者中探讨JAK2V617F中性粒细胞是否足以促进血栓形成。结果显示,仅表达突变的中性粒细胞不足以诱导自发性NETosis或肺血栓,需JAK2V617F血小板与中性粒细胞协同才能促进体内NETosis;阿司匹林可减少小鼠NETosis和肺血栓,且接受阿司匹林治疗的MPN患者血浆NET标志物浓度低于未治疗者。

要点

  • 仅JAK2V617F中性粒细胞不足以诱导自发性NETosis和肺血栓形成。
  • JAK2V617F血小板与中性粒细胞协同促进体内NETosis。
  • 阿司匹林减少小鼠NETosis和肺血栓,并与患者NET标志物降低相关。

核心结论

  • JAK2V617F中性粒细胞单独不足以促进血栓形成,血小板与中性粒细胞协同促进体内NETosis。
  • 研究还发现了阿司匹林在MPN血栓预防中的新作用。

研究设计与样本

  • 研究在PF4iCre;Jak2V617F/WT小鼠(所有造血谱系表达JAK2V617F,如MPN所见)和MRP8Cre;Jak2V617F/WT小鼠(仅白细胞表达JAK2V617F)中研究NETosis。
  • 接受阿司匹林治疗的无细胞减灭治疗MPN患者与未接受阿司匹林治疗的MPN患者血浆NET标志物浓度进行比较。

主要发现

  • PF4iCre;Jak2V617F/WT小鼠中观察到NETosis增加和自发性肺血栓形成,DNAse给药可消除该血栓形成。
  • MRP8Cre;Jak2V617F/WT小鼠中无自发性NETosis或肺血栓形成,提示仅突变中性粒细胞不足以诱导血栓形成。
  • 离体实验表明JAK2V617F突变血小板触发JAK2V617F突变中性粒细胞发生NETosis。
  • PF4iCre;Jak2V617F/WT小鼠中阿司匹林治疗减少NETosis并减少肺血栓形成。
  • 接受阿司匹林治疗的无细胞减灭治疗MPN患者血浆NET标志物浓度低于未接受阿司匹林治疗的MPN患者。

临床怎么用

  • 作者认为血小板与中性粒细胞协同促进体内NETosis,并识别出阿司匹林在MPN血栓预防中的新作用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Neutrophils participate in the pathogenesis of thrombosis through the formation of neutrophil extracellular traps (NETs). Thrombosis is the main cause of morbidity and mortality in patients with myeloproliferative neoplasms (MPNs). Recent studies have shown an increase in NET formation (NETosis) both in patients with JAK2V617F neutrophils and in mouse models, and reported the participation of NETosis in the pathophysiology of thrombosis in mice. OBJECTIVES: This study investigated whether JAK2V617F neutrophils are sufficient to promote thrombosis or whether their cooperation with other blood cell types is necessary. METHODS: NETosis was studied in PF4iCre;Jak2V617F/WT mice expressing JAK2V617F in all hematopoietic lineages, as occurs in MPNs, and in MRP8Cre;Jak2V617F/WT mice in which JAK2V617F is expressed only in leukocytes. RESULTS: In PF4iCre;Jak2V617F/WT mice, an increase in NETosis and spontaneous lung thrombosis abrogated by DNAse administration were observed. The absence of spontaneous NETosis or lung thrombosis in MRP8Cre;Jak2V617F/WT mice suggested that mutated neutrophils alone are not sufficient to induce thrombosis. Ex vivo experiments demonstrated that JAK2V617F-mutated platelets trigger NETosis by JAK2V617F-mutated neutrophils. Aspirin treatment in PF4iCre;Jak2V617F/WT mice reduced NETosis and reduced lung thrombosis. In cytoreductive-therapy-free patients with MPN treated with aspirin, plasma NET marker concentrations were lower than that in patients with MPN not treated with aspirin. CONCLUSION: Our study demonstrates that JAK2V617F neutrophils alone are not sufficient to promote thrombosis; rather, platelets cooperate with neutrophils to promote NETosis in vivo. A new role for aspirin in thrombosis prevention in MPNs was also identified.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Guy A, Garcia G, Gourdou-Latyszenok V, et al. Platelets and neutrophils cooperate to induce increased neutrophil extracellular trap formation in JAK2V617F myeloproliferative neoplasms. J Thromb Haemost. 2023. PMID: 37678548. doi:10.1016/j.jtha.2023.08.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。